{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:51Z","timestamp":1792174971733,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Investissements d\u2019Avenir"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.tem.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T02:28:01Z","timestamp":1504232881000},"page":"807-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma"],"prefix":"10.1016","volume":"28","author":[{"given":"David","family":"Ta\u00efeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2017.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/onc.2015.172","article-title":"Rethinking pheochromocytomas and paragangliomas from a genomic perspective","volume":"35","author":"Castro-Vega","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2017.08.001_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","article-title":"The genomic landscape of phaeochromocytoma","volume":"236","author":"Flynn","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.tem.2017.08.001_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0025","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0040","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tem.2017.08.001_bib0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tibs.2017.01.003","article-title":"Mitochondrial complex II: at the crossroads","volume":"42","author":"Bezawork-Geleta","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tem.2017.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tem.2017.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2017.08.001_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.ejhg.5201904","article-title":"Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD","volume":"16","author":"Pasini","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0065","doi-asserted-by":"crossref","first-page":"E1482","DOI":"10.1210\/jc.2013-3853","article-title":"The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)","volume":"99","author":"Else","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.08.001_bib0070","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"15 Years of paraganglioma: clinical manifestations of paraganglioma syndromes types 1\u20135","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0075","doi-asserted-by":"crossref","first-page":"L43","DOI":"10.1530\/ERC-17-0030","article-title":"SDHA mutated paragangliomas may be at high risk of metastasis","volume":"24","author":"Tufton","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmg.30.2.104","article-title":"Detailed genetic mapping of the von Hippel\u2013Lindau disease tumour suppressor gene","volume":"30","author":"Richards","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0085","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0105","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driven tumorigenesis: from genetics to targeted therapy","volume":"135","author":"Morin","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0110","doi-asserted-by":"crossref","first-page":"32955","DOI":"10.18632\/oncotarget.5106","article-title":"Deciphering the molecular basis of invasiveness in Sdhb-deficient cells","volume":"6","author":"Loriot","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2017.08.001_bib0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2008.11.008","article-title":"Mitochondria in cancer: not just innocent bystanders","volume":"19","author":"Frezza","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tem.2017.08.001_bib0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccr.2013.05.015","article-title":"Succinate: a new epigenetic hacker","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.1173362","article-title":"Puzzling patterns of predisposition","volume":"324","author":"Pollard","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tem.2017.08.001_bib0130","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.01338-07","article-title":"Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis","volume":"28","author":"Guzy","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2017.08.001_bib0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","article-title":"Succinate: a metabolic signal in inflammation","volume":"24","author":"Mills","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tem.2017.08.001_bib0140","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.117.192674","article-title":"The evolving role of succinate in tumor metabolism: an 18F-FDG-based study","author":"Garrigue","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0145","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1158\/1078-0432.CCR-16-0606","article-title":"Pheochromocytoma: the first metabolic endocrine cancer","volume":"22","author":"Jochmanova","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djt201","article-title":"Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction","volume":"105","author":"Jochmanova","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tem.2017.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2967\/jnumed.114.137034","article-title":"Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma","volume":"55","author":"van Berkel","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0160","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1158\/0008-5472.CAN-07-5580","article-title":"Cells silenced for SDHB expression display characteristic features of the tumor phenotype","volume":"68","author":"Cervera","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tem.2017.08.001_bib0180","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0190","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0195","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Cascon","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tem.2017.08.001_bib0200","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"Lopez-Jimenez","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2017.08.001_bib0205","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","article-title":"The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion","volume":"71","author":"Koh","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11060-011-0625-2","article-title":"IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients","volume":"105","author":"Metellus","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.tem.2017.08.001_bib0215","article-title":"Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors","author":"Lorendeau","year":"2016","journal-title":"Metab Eng."},{"key":"10.1016\/j.tem.2017.08.001_bib0220","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/ncomms9784","article-title":"Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism","volume":"6","author":"Lussey-Lepoutre","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2017.08.001_bib0225","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ncb3233","article-title":"Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis","volume":"17","author":"Cardaci","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tem.2017.08.001_bib0230","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv287","article-title":"SDHB-deficient cancers: the role of mutations that impair iron sulfur cluster delivery","volume":"108","author":"Saxena","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tem.2017.08.001_bib0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12672-014-0172-3","article-title":"Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation","volume":"5","author":"Rapizzi","year":"2014","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/ERC-14-0479","article-title":"Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function","volume":"22","author":"Rapizzi","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neo.2014.10.010","article-title":"Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications","volume":"17","author":"Imperiale","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.tem.2017.08.001_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080539","article-title":"A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas","volume":"8","author":"Imperiale","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2017.08.001_bib0255","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.1210\/jc.2014-2138","article-title":"Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics","volume":"100","author":"Rao","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.08.001_bib0260","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1530\/ERC-15-0246","article-title":"Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics","volume":"22","author":"Varoquaux","year":"2015","journal-title":"Endocr-Relat Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0265","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma","volume":"22","author":"Lussey-Lepoutre","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0270","doi-asserted-by":"crossref","first-page":"33737","DOI":"10.1074\/jbc.M111.266890","article-title":"Effects of excess succinate and retrograde control of metabolite accumulation in yeast tricarboxylic cycle mutants","volume":"286","author":"Lin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2017.08.001_bib0275","doi-asserted-by":"crossref","first-page":"27518","DOI":"10.1074\/jbc.M700601200","article-title":"Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate","volume":"282","author":"Szeto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2017.08.001_bib0280","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/pr100880y","article-title":"Mutations in the Saccharomyces cerevisiae succinate dehydrogenase result in distinct metabolic phenotypes revealed through 1H NMR-based metabolic footprinting","volume":"9","author":"Szeto","year":"2010","journal-title":"J. Proteome. Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0285","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2017.08.001_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/en.2013-1549","article-title":"Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB\/D-related paraganglioma: initial experimental and ex vivo findings","volume":"155","author":"Lendvai","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2017.08.001_bib0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12964-016-0126-1","article-title":"GPR91: expanding the frontiers of Krebs cycle intermediates","volume":"14","author":"de Castro Fonseca","year":"2016","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.tem.2017.08.001_bib0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.1873","article-title":"The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis","volume":"14","author":"Sapieha","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0305","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tem.2017.08.001_bib0310","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.08.001_bib0315","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","article-title":"Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis","volume":"39","author":"Treglia","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2017.08.001_bib0320","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.08.001_bib0325","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cen.12126","article-title":"Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by 18F-FDOPA PET: focus on missed lesions","volume":"79","author":"Gabriel","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2017.08.001_bib0330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00259-016-3586-z","article-title":"18F-fluorodihydroxyphenylalanine PET\/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L","volume":"44","author":"Feral","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2017.08.001_bib0335","doi-asserted-by":"crossref","first-page":"30411","DOI":"10.1074\/jbc.M113.490698","article-title":"Identification of cysteine residues in human cationic amino acid transporter hCAT-2A that are targets for inhibition by N-ethylmaleimide","volume":"288","author":"Beyer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2017.08.001_bib0340","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.4158\/EP15759.CR","article-title":"Functional imaging experience in a germline fumarate hydratase mutation\u2013positive patient with pheochromocytoma and paraganglioma","volume":"2","author":"Nambuba","year":"2016","journal-title":"AACE Clinical Case Reports"},{"key":"10.1016\/j.tem.2017.08.001_bib0345","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s00259-013-2548-y","article-title":"A retrospective comparison between 68Ga-DOTA-TOC PET\/CT and 18F-DOPA PET\/CT in patients with extra-adrenal paraganglioma","volume":"40","author":"Kroiss","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2017.08.001_bib0350","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2017.08.001_bib0355","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2017.08.001_bib0360","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2017.08.001_bib0365","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tem.2017.08.001_bib0370","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.tem.2017.08.001_bib0375","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/ERC-16-0231","article-title":"Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome","volume":"23","author":"Darr","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2017.08.001_bib0380","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.18632\/oncotarget.14485","article-title":"Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation","volume":"8","author":"Mu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2017.08.001_bib0385","article-title":"Succinate: an initiator in tumorigenesis and progression","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2017.08.001_bib0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/bj1170091","article-title":"Effects of ischaemia on metabolite concentrations in rat liver","volume":"117","author":"Brosnan","year":"1970","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2017.08.001_bib0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tem.2017.08.001_bib0400","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nature02488","article-title":"Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors","volume":"429","author":"He","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tem.2017.08.001_bib0405","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276017301030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276017301030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T06:36:29Z","timestamp":1535438189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276017301030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1043276017301030"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2017.08.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}